KRAS and cancer: In human patients, KRAS mutations are detected in >90% of early staged pre-cancerous pancreatic intraepithelial neoplasias (PanINs) [26], but transformation to full-blown cancer occurs at a very low incidence, and is more much likely in patients with chronic pancreatitis or obesity, conditions which are associated with chronic systemic inflammation [27,28,29].